冠状动脉支架市场规模、份额、成长分析、按类型、按交付、按材料、按最终用户、按地区 - 2024-2031 年行业预测

Coronary Stent Market Size, Share, Growth Analysis, By Type (Bare-Metal Stents, Drug-Eluting Stents), By Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Material, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球冠状动脉支架市场规模为99亿美元，从2023年的102.2亿美元成长到2031年的131.4亿美元，复合年增长率预计为3.2%。

由于心血管疾病的快速增加、人口老化以及对微创手术的日益偏好，全球冠状动脉支架市场正在经历显着增长。由于生活方式的改变和不健康的饮食导致这些疾病的盛行率增加，对冠状动脉支架的需求正在增加。药物释放型和生物可吸收支架等创新正在改善患者的治疗效果和安全性，并正在摆脱传统的裸金属支架。然而，市场面临支架治疗成本高昂的挑战，这可能限制低收入地区的使用，以及製造商必须克服的监管障碍。此外，支架血栓症和血管再阻塞等潜在併发症仍然是患者和医疗保健提供者关注的问题，影响市场动态。

雅培实验室（美国）
美敦力公司（爱尔兰）
波士顿科学公司（美国）
博森国际集团有限公司（新加坡）
BIoTronik SE & Co. KG（德国）
B.Braun Melsungen AG（德国）
泰尔茂株式会社（日本）
微创医疗科技有限公司 (中国)
乐普医疗科技(北京)有限公司 (中国)
萨哈贾南德医疗技术私人有限公司（印度）
Meril 生命科学私人有限公司（印度）
血管概念（印度）
Translumina 有限公司（德国）
康迪斯公司（美国）
Reva Medical, Inc.（美国）
Elixir 医疗公司（美国）
Stentys SA（法国）
Alvimedica（土耳其）
博尔顿医疗（瑞典）
Cardionovum（美国）

结论和建议

简介目录

Product Code: SQMIG35A2668

Global Coronary Stent Market size was valued at USD 9.9 billion in 2022 and is poised to grow from USD 10.22 billion in 2023 to USD 13.14 billion by 2031, growing at a CAGR of 3.2% during the forecast period (2024-2031).

The global coronary stent market is experiencing notable growth, driven by a surge in cardiovascular diseases, an aging population, and increasing preference for minimally invasive procedures. As lifestyle changes and unhealthy diets contribute to the rising incidence of these conditions, the demand for coronary stents is heightened. Technological innovations, such as drug-eluting and bioresorbable stents, have enhanced patient outcomes and safety, promoting a transition from traditional bare-metal options. However, the market faces challenges, including the high costs of stent procedures, which may restrict access in lower-income regions, along with stringent regulatory hurdles that manufacturers must navigate. Additionally, potential complications like stent thrombosis and restenosis remain concerns for patients and healthcare providers alike, affecting market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coronary Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Stent Market Segmental Analysis

Global Coronary Stent Market is segmented by type, delivery, material, end user and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. Based on delivery, the market is segmented into balloon-expandable stents and self-expanding stents. Based on material, the market is segmented into metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel and other stents. Based on end user, the market is segmented into hospitals, cardiac centers and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coronary Stent Market

The global coronary stent market is significantly driven by the escalating prevalence of cardiovascular diseases, particularly coronary artery disease. Factors such as unhealthy dietary habits, sedentary lifestyles, and other lifestyle modifications have contributed to an alarming rise in these health conditions worldwide. As more individuals are diagnosed with cardiovascular ailments, the demand for effective treatments, including coronary stents, continues to increase. This growing health crisis emphasizes the need for innovative medical solutions, making coronary stents an essential component in the management and treatment of heart-related diseases, thus propelling the market forward.

Restraints in the Global Coronary Stent Market

The Global Coronary Stent market faces significant constraints due to stringent regulatory approval processes instituted by governing bodies. These rigorous requirements necessitate comprehensive safety and efficacy evaluations, which can be both time-consuming and resource-draining for manufacturers. Consequently, these lengthy approval timelines can hinder the timely introduction of innovative products into the market, stalling overall market growth and limiting competitiveness. As companies navigate the complexities of compliance, the potential for delays in product launches becomes a notable barrier, impacting their ability to respond swiftly to evolving market demands and capitalize on emerging opportunities.

Market Trends of the Global Coronary Stent Market

The global coronary stent market is witnessing a significant trend towards minimally invasive procedures, particularly percutaneous coronary intervention (PCI). This shift is fueled by an increasing patient preference for treatments that promise shorter hospital stays, faster recovery times, and reduced risks of complications compared to conventional open-heart surgeries. As healthcare professionals and patients alike recognize the advantages of these less invasive techniques, the demand for advanced coronary stents is surging. Furthermore, technological advancements in stent design and materials are enhancing efficacy and safety, solidifying their role in contemporary cardiovascular care and ensuring robust market growth in the upcoming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Coronary Stent Market Size by Type & CAGR (2024-2031)

Market Overview
Bare-Metal Stents
Drug-Eluting Stents
Bioabsorbable Stents

Global Coronary Stent Market Size by Delivery & CAGR (2024-2031)

Market Overview
Balloon-Expandable Stents
Self-Expanding Stents

Global Coronary Stent Market Size by Material & CAGR (2024-2031)

Market Overview
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

Global Coronary Stent Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Global Coronary Stent Market Size & CAGR (2024-2031)

North America (Type, Delivery, Material, End User)
- US
- Canada
Europe (Type, Delivery, Material, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Delivery, Material, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Delivery, Material, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Delivery, Material, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sahajanand Medical Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Concepts (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Translumina GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reva Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elixir Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stentys SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alvimedica (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balton Medical (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardionovum (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments